2022-2030 Novel Drug Delivery Systems (NDDS) Market Research Report - Regional Analysis, Top Players, Growth, Shares, Revenue

Detailed TOC of 2022-2030 Novel Drug Delivery Systems (NDDS) Market Research Report - Regional Analysis, Top Players, Growth, Shares, Revenue

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Requirement of Controlled Release of Drugs
6.1.2 Advancement in Pharmacology Promoting Increased Adoption of Novel Drug Delivery Systems (NDDS)
6.1.3 Technological Advancements Promoting Development of NDDS
6.2 Market Restraints
6.2.1 Stringent Regulatory Guidelines
6.2.2 Product Recalls
6.2.3 Stability Issues
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Route of Administration
7.1.1 Oral Drug Delivery Systems
7.1.2 Injectable Drug Delivery Systems
7.1.3 Pulmonary Drug Delivery Systems
7.1.4 Transdermal Drug Delivery Systems
7.1.5 Others
7.2 By Mode of NDDS
7.2.1 Targeted Drug Delivery Systems
7.2.2 Controlled Drug Delivery Systems
7.2.3 Modulated Drug Delivery Systems
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia & New Zealand
7.3.3.5 South Korea
7.3.3.6 Rest of Asia-Pacific
7.3.4 Middle East & Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of the Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Abbott Laboratories
9.2 AstraZeneca PLC
9.3 Bayer Healthcare Pharmaceuticals
9.4 GlaxoSmithKline PLC
9.5 Johnson & Johnson
9.6 Merck & Co.
9.7 Novartis AG
9.8 Pfizer Inc.
9.9 Roche Holding AG
9.10 Sanofi SA
9.11 List Not Exhaustive
10. Future of the Market